Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  Roche Holding Ltd.    RHO5   CH0012032048

End-of-day quote. End-of-day quote  - 02/12
223.634 EUR   +2.40%
02/03 Seven $1 billion-plus drugs seen reaching market in 2016
01/28 Oil climbs on hopes for output cut, dollar slips
01/28 Roche annual profit disappoints, outlook muted
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ROCHE HOLDING LTD.
02/03 Seven $1 billion-plus drugs seen reaching market in 2016
01/28 Oil climbs on hopes for output cut, dollar slips
01/28 Roche annual profit disappoints, outlook muted
01/28DJRoche Profit Dented by Strong Swiss Franc -- 2nd Update
01/28DJU.S. Stocks Climb, Along With Oil
01/28DJRoche Profit Dented by Strong Swiss Franc -- Update
01/28DJRoche Profit Dented by Strong Swiss Franc
01/28DJROCHE : Profit Dented by Strong Swiss Franc
01/25DJRoche Holding AG Full-year 2015 -- Forecast
01/20DJDrug and Diagnostic Companies Issue Joint Declaration on Antibiotics
01/20DJAbbVie Leukemia Therapy Granted FDA Breakthrough Designation
01/17DJSamsung Gets European Approval for Enbrel Copy
01/12DJAbbVie, Genentech Leukemia Therapy Granted FDA Priority Review
01/12DJAbbVie, Genentech Leukemia Therapy Granted FDA Priority Review
01/12 ROCHE : Fda grants priority review for venetoclax new drug application
01/11 Drugmaker Shire buys Baxalta for $32 billion after six-month pursuit
01/11 Drugmaker Shire buys Baxalta for $32 billion after six-month pursuit
01/11DJShire to Buy Baxalta for $32 Billion After Six-Month Pursuit
01/08DJIllumina Files Patent Suit Against Premaitha's Customer in Poland
2015DJStandoff Over Shire's Pursuit of Baxalta Nears an End
2015 GSK gets lift from successful arthritis drug trials
2015DJSanofi, Boehringer in Talks Over Asset Swap
2015DJLilly's Lung-Cancer Drug Portrazza to Cost $11,430 a Month
2015DJLilly's Lung-Cancer Drug Portrazza to Cost $11,430 a Month
2015 ROCHE : FDA Grants Genentech’s Alecensa® (Alectinib) Accelerated Approval ..
2015DJU.S. Stocks Fall as Oil Keeps Sliding
2015 ROCHE : Pivotal Phase II Study Showed Nearly 80 Percent of People with Hard-to-T..
2015 ROCHE : New results from cll11 study show gazyva® provided people with previousl..
2015DJSamsung to Invest $740 Million in New Drug Facility
2015 ROCHE : UPDATED DATA SHOWED THAT COTELLIC™ (COBIMETINIB) IN COMBINATION WI..
2015 AstraZeneca's potential $3 billion cancer pill wins early approval
2015DJRoche Plans to Exit Four Plants as Focus Shifts to Specialty Drugs
2015DJRoche Plans to Exit Four Plants as Focus Shifts to Specialty Drugs
2015 Roche to take $1.6 billion charge to close sites in Europe, U.S.
2015DJROCHE : FDA Approves Roche's Cotellic Treatment for Melanoma
2015DJROCHE : FDA Approves Roche's Cotellic Treatment for Melanoma
2015 ROCHE : FDA Approves Genentech’s Cotellic™ (cobimetinib) in Combinat..
2015DJSanofi May Sell Generic Drug, Animal Health Businesses
2015 ROCHE : Genentech : to Present New Clinical Data Across a Variety of Blood Disea..
2015 AstraZeneca cancer drug may not be so fast getting to market
2015 ROCHE : convinced its new drugs can mitigate biosimilars risks
2015 Stocks rally, euro falls as ECB open to more stimulus
2015DJRoche Raises Full-Year Outlook -- 2nd Update
2015DJRoche Raises Full-Year Outlook
2015DJRoche Expects Strong Growth From Recent Breast Cancer Drugs
2015DJRoche Raises Full-Year Outlook -- Update
2015DJRoche Posts Slight Rise in Third-Quarter Sales to CHF11.94 Billion
2015DJRoche Holding AG 3Q 2015 -- Forecast
2015DJRoche Holding AG 3Q 2015 -- Forecast
2015 EXCLUSIVE - TRANSATLANTIC DIVIDE : how U.S. pays three times more for drugs
2015DJLilly to Halt Cholesterol-Drug Development
2015DJJudge Rejects H-P Settlement of Shareholder Suit Over Aruba Merger -- Update
2015DJRoche Reports Positive Late-Stage Trial Results for MS Drug--2nd Update
2015DJRoche Reports Positive Late-Stage Trial Results for MS Drug--2nd Update
2015DJROCHE : Reports Positive Late-Stage Trial Results for MS Drug--Update
2015DJRoche's MS Drug Shows Promising Results
2015DJROCHE : Reports Positive Late-Stage Trial Results for MS Drug
2015 ROCHE : Genentech :’s Ocrelizumab First Investigational Medicine to Show P..
2015 Faint corporate praise for TPP as winners, losers sought
2015 Faint corporate praise greets TPP trade deal
2015 Historic Pacific trade deal faces skeptics in Congress
2015 Historic Pacific trade deal faces sceptics in U.S. Congress
2015 Late delay as Pacific trade talks near landmark deal
2015 ROCHE : GENENTECH’S OCRELIZUMAB FIRST INVESTIGATIONAL MEDICINE TO SHOW EFF..
2015 ROCHE : Two Positive Studies of Genentech’s Investigational Cancer Immunot..
2015 ROCHE : Genentech : Presents Positive Results from Pivotal Study of Investigatio..
2015DJAmgen, Allergan Biosimilar Lung-Cancer Therapy Shows Positive Results
2015DJCorrection to Biosimilar Story on Tuesday
2015DJAmgen, Allergan Biosimilar Lung-Cancer Therapy Shows Positive Results
2015DJNew Weapon in Push to Lower U.S. Biotech Drug Prices
2015DJGOLDMAN'S LLOYD BLANKFEIN : How to Understand a Lymphoma Diagnosis
2015 Craig Venter's company in deal for whole exome tests at new low cost
2015DJBristol-Myers' Opdivo Gets Breakthrough Status for Kidney Cancer
2015DJBristol-Myers' Opdivo Gets Breakthrough Status for Kidney Cancer
2015DJRoche 'Very Unlikely' to Pursue a Midsize Acquisition Soon
1  2  3  4  5  6  7  8  9  10Next
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials